Various combined treatments, such as anti-PD1/PD-L1 combined with angiogenesis inhibitors, targeted therapies, other immune checkpoint inhibitors, or metabolic modulators, are proven to be more effective against cancer than monotherapy.[32]. The gene discussed is PDCD1; the disease is cancer.